Tag: GLOG

  • Stocks Getting Hot: Akamai Technologies (NASDAQ:AKAM), Westport Innovations (NASDAQ:WPRT), GasLog Ltd (NYSE:GLOG), SandRidge Energy (NYSE:SD), bluebird bio (NASDAQ:BLUE)

    Akamai Technologies Inc. (NASDAQ:AKAM) should see a Q2 boost in online video streaming from soccer’s World Cup as well as a long-term gain from Microsoft’s refocus on its Xbox One gaming console, says Oppenheimer. Akamai Technologies, Inc. (NASDAQ:AKAM) stock opened today at $58.74 and is currently trading at $60.37. The stock showed a positive weekly performance of 2.38%.

    Westport Innovations Inc., (USA) (NASDAQ:WPRT) a specialist in natural gas engines and systems, on 6 June has appointed Ashoka Achuthan chief financial officer and Bill Larkin as vice president of corporate development. Westport Innovations Inc. (USA) (NASDAQ:WPRT) stock opened at $15.00, in current trading session and currently is at $15.67, by gaining 4.68%. The 52 week range of $12.42 – $35.40. Company’s market capitalization is 941.36 million.

    Evercore Partners lifted their price target on shares of GasLog Ltd (NASDAQ:GLOG) from $20.00 to $25.00 in a research note issued on Thursday. The firm currently has an “overweight” rating on the stock. Evercore Partners’ target price would indicate a potential upside of 0.97% from the company’s current price. GasLog Ltd (NYSE:GLOG) stock is currently trading at $26.18. The EPS of the stock is 0.90. Company’s market capitalization is 2.12 billion.

    SandRidge Energy Inc. (NYSE:SD) Director William A. Gilliland unloaded 1,721,355 shares of the company’s stock in a transaction that occurred on Monday, June 9th. The shares were sold at an average price of $6.77, for a total transaction of $11,653,573.35. Following the completion of the sale, the director now directly owns 103,115 shares in the company, valued at approximately $698,089. SandRidge Energy Inc. (NYSE:SD) stock opened the session at $6.99, and now is at $7.12. The 52 week range of the SandRidge Energy Inc. (NYSE:SD) stock remained $4.68 – $7.20 and the day range was $6.95 – $7.20.

    bluebird bio Inc. (NASDAQ:BLUE) announced initial positive clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects on Saturday. bluebird bio Inc. (NASDAQ:BLUE) stock opened today at $41.50 and is currently trading at $35.07. The stock showed a positive weekly performance of 12.22%.